Publication: Hepatitis C and kidney disease: An overview and approach to management
dc.contributor.author | Azmi, AN | en_US |
dc.contributor.author | Tan, SS | en_US |
dc.contributor.author | Mohamed, R | en_US |
dc.date.accessioned | 2024-05-29T02:50:19Z | |
dc.date.available | 2024-05-29T02:50:19Z | |
dc.date.issued | 2015 | |
dc.description.abstract | Hepatitis C infection and chronic kidney disease are major health burden worldwide. Hepatitis C infection is associated with a wide range of extra-hepatic manifestations in various organs including the kidneys. A strong association between hepatitis C and chronic kidney disease has come to light. Hemodialysis in supporting the end stage renal disease patients unfortunately carries a risk for hepatitis C infection. Despite much improvement in the care of this group of patients, the prevalence of hepatitis C infection in hemodialysis patients is still higher than the general population. Hepatitis C infection has a negative effect on the survival of hemodialysis and renal transplant patients. Treatment of hepatitis C in end stage renal disease patients using conventional or pegylated interferon with or without ribavirin remains a clinical challenge with low response rate, high dropout rate due to poor tolerability and many unmet needs. The approval of new direct acting antiviral agents for hepatitis C may dramatically change the treatment approach in hepatitis C infected patients with mild to moderate renal impairment. However it remains to be confirmed if the newer Hepatitis C therapies are safe in individuals with severe renal impairment. This review article discusses the relationship between hepatitis C and chronic kidney disease, describe the various types of renal diseases associated with hepatitis C and the newer as well as the existing treatments for hepatitis C in the context of this subpopulation of hepatitis C patients. | |
dc.identifier.doi | 10.4254/wjh.v7.i1.78 | |
dc.identifier.epage | 92 | |
dc.identifier.issn | 1948-5182 | |
dc.identifier.issue | 1 | |
dc.identifier.scopus | WOS:000439184000009 | |
dc.identifier.spage | 78 | |
dc.identifier.uri | https://oarep.usim.edu.my/handle/123456789/11038 | |
dc.identifier.volume | 7 | |
dc.language | English | |
dc.language.iso | en_US | |
dc.publisher | Baishideng Publishing Group Inc | en_US |
dc.relation.ispartof | World Journal Of Hepatology | |
dc.source | Web Of Science (ISI) | |
dc.subject | Chronic hepatitis C | en_US |
dc.subject | Kidney disease | en_US |
dc.subject | Management | en_US |
dc.title | Hepatitis C and kidney disease: An overview and approach to management | |
dc.type | Article | en_US |
dspace.entity.type | Publication |